This study has a compensation of up to $1,620 for time and travel for qualified participants.
Receive $100 for all qualified referrals.
Overview
This trial will evaluate the safety, effectiveness, and immune response of an investigational vaccine aimed at preventing norovirus disease in adults.
Norovirus, often called “food poisoning” or the “stomach bug”, can cause major disruptions to your daily life. Symptoms can include sudden nausea, vomiting, diarrhea, stomach pain, feeling tired or weak, muscle pains, and fever. These symptoms, often known as acute gastroenteritis (AGE), generally last for 1 to 3 days. In severe cases, these symptoms can lead to dehydration, which may require hospitalization or IV fluids.
Norovirus spreads quickly through interactions in places like day care centers, retirement communities, cruise ships, and restaurants. Children under age 5, adults over age 60, and people with underlying health conditions are at greater risk of serious symptoms of norovirus.
mRNA, messenger RNA vaccines, aim to teach the body how to make a specific protein that may potentially help your immune system prevent or treat certain diseases. The hope is that the vaccine trains your immune system cells to “remember” these proteins and help your body quickly protect against the strain of infection if exposed in the future. You cannot get norovirus from the investigational vaccine.
Who can join the study?
- Participants Must:
- Be 60 years of age or older
- Be in generally good health, including well-controlled chronic medical conditions
- Participants Must Not:
- Be pregnant or planning on becoming pregnant for at least 3 months following the injection visit
Ages
60 and over
Study Topics
Vaccine
See If You Qualify For This Study
About Norovirus
Norovirus is an extremely contagious virus that can spread quickly through everyday social interactions causing a quick onset of symptoms like nausea, vomiting, and diarrhea. These symptoms, often known as acute gastroenteritis (AGE), usually last 1 to 3 days. In severe cases these symptoms can lead to dehydration which may require hospitalization or IV fluids. While norovirus can infect people of all ages, vulnerable people such as children under age 5, adults over age 60, and people with underlying health conditions are at greater risk of serious symptoms. Norovirus is the leading cause of acute gastroenteritis.
Why participate in this study?
Qualified participants will receive at no cost
- Study-related physical exams
- Study-related lab work
- Study-related procedures
Compensation up to $1,620 for time and travel for qualified participants.
This research study is enrolling people who:
60 and over
In general good health, including well-controlled chronic medical conditions
Not pregnant or planning on becoming pregnant for at least 3 months following the injection visit
Do You Not Meet the Criteria for This Study?
You could still participate in other studies. Contact us to be added to our database and you’ll be notified about our future studies that may be right for you.
